The Association of Metabolic Brain MRI , Amyloid PET , and Clinical Factors: A Study of Alzheimer's Disease and Normal Controls From the Open Access Series of Imaging Studies Dataset
Journal of Magnetic Resonance Imaging · 2024-04 · 59 (4) · 1341-1348
DOI: 10.1002/jmri.28892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 09.07.2023. Verfasst von Shu Matsushita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Although brain activities in Alzheimer's disease (AD) might be evaluated MRI and PET, the relationships between brain temperature (BT), the index of diffusivity along the perivascular space (ALPS index), and amyloid deposition in the cerebral cortex are still unclear.
Purpose
To investigate the relationship between metabolic imaging measurements and clinical information in patients with AD and normal controls (NCs). Study Type Retrospective analysis of a prospective dataset. Population 58 participants (78.3 ± 6.8 years; 30 female): 29 AD patients and 29 age‐ and sex‐matched NCs from the Open Access Series of Imaging Studies dataset. Field Strength/Sequence 3T; T1‐weighted magnetization‐prepared rapid gradient‐echo, diffusion tensor imaging with 64 directions, and dynamic 18 F‐florbetapir PET. Assessment Imaging metrics were compared between AD and NCs. These included BT calculated by the diffusivity of the lateral ventricles, ALPS index that reflects the glymphatic system, the mean standardized uptake value ratio (SUVR) of amyloid PET in the cerebral cortex and clinical information, such as age, sex, and MMSE. Statistical Tests Pearson's or Spearman's correlation and multiple linear regression analyses. P values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
- Smart Life Science Lab, Center for Health Science Innovation, Osaka Metropolitan University, Osaka, Japan.
ORCID-Profile: Shu Matsushita, Hiroyuki Tatekawa, Daiju Ueda, Hirotaka Takita, Daisuke Horiuchi, Taro Tsukamoto, Taro Shimono, Yukio Miki
Förderung
- Japan Society for the Promotion of Science
- Takeda Science Foundation
- NIA NIH HHS
- NINDS NIH HHS
- NCATS NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Matsushita, S., Tatekawa, H., Ueda, D., Takita, H., Horiuchi, D., Tsukamoto, T., Shimono, T., & Miki, Y. (2024). The Association of Metabolic Brain MRI , Amyloid PET , and Clinical Factors: A Study of Alzheimer's Disease and Normal Controls From the Open Access Series of Imaging Studies Dataset. Journal of Magnetic Resonance Imaging, 59(4), 1341-1348. https://doi.org/10.1002/jmri.28892
Vancouver
Matsushita S, Tatekawa H, Ueda D, Takita H, Horiuchi D, Tsukamoto T, et al. The Association of Metabolic Brain MRI , Amyloid PET , and Clinical Factors: A Study of Alzheimer's Disease and Normal Controls From the Open Access Series of Imaging Studies Dataset. Journal of Magnetic Resonance Imaging. 2024;59(4):1341-1348. doi:10.1002/jmri.28892
BibTeX
@article{Matsushita2024,
author = {Matsushita, Shu and Tatekawa, Hiroyuki and Ueda, Daiju and Takita, Hirotaka and Horiuchi, Daisuke and Tsukamoto, Taro and Shimono, Taro and Miki, Yukio},
title = {The Association of Metabolic Brain MRI , Amyloid PET , and Clinical Factors: A Study of Alzheimer's Disease and Normal Controls From the Open Access Series of Imaging Studies Dataset},
journal = {Journal of Magnetic Resonance Imaging},
year = {2024},
volume = {59},
number = {4},
pages = {1341--1348},
doi = {10.1002/jmri.28892}
}
EUVIMED